We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+14.03%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$5.25B
AUM Growth
+$2.55B
Cap. Flow
+$1.83B
Cap. Flow %
34.94%
Top 10 Hldgs %
32.08%
Holding
1,322
New
459
Increased
205
Reduced
157
Closed
337

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$19.5M
2
BYND icon
Beyond Meat
BYND
+$7.54M
3
RUN icon
Sunrun
RUN
+$7.26M
4
AMCX icon
AMC Global Media
AMCX
+$5.07M
5
QRVO icon
Qorvo
QRVO
+$4.19M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 7.87%
2 Communication Services 0.75%
3 Technology 0.67%
4 Healthcare 0.67%
5 Industrials 0.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTXS
1276
DELISTED
Citrix Systems Inc
CTXS
-13,800
Closed -$1.9M
CTXS
1277
PUT
DELISTED
Citrix Systems Inc
CTXS
-13,800
Closed -$1.9M
MNDT
1278
DELISTED
Mandiant, Inc. Common Stock
MNDT
-25,000
Closed -$385K
WBT
1279
CALL
DELISTED
Welbilt, Inc.
WBT
-100,000
Closed -$616K
CERN
1280
CALL
DELISTED
Cerner Corp
CERN
-247,000
Closed -$17.9M
CERN
1281
PUT
DELISTED
Cerner Corp
CERN
-2,900
Closed -$210K
EVFM
1282
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
-13,200
Closed -$467K
CONE
1283
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
-15,000
Closed -$1.05M
CONE
1284
PUT
DELISTED
CyrusOne Inc Common Stock
CONE
-15,000
Closed -$1.05M
DRNA
1285
CALL
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-30,000
Closed -$540K
DRNA
1286
PUT
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-30,000
Closed -$540K
KSU
1287
CALL
DELISTED
Kansas City Southern
KSU
-24,300
Closed -$4.39M
XLRN
1288
CALL
DELISTED
Acceleron Pharma
XLRN
-15,000
Closed -$1.69M
XLRN
1289
PUT
DELISTED
Acceleron Pharma
XLRN
-15,000
Closed -$1.69M
HZAC.U
1290
DELISTED
Horizon Acquisition Corporation Units, each consisting of one Class A ordinary share and one-third o
HZAC.U
-2,500
Closed -$26K
HOME
1291
CALL
DELISTED
At Home Group Inc.
HOME
-100,000
Closed -$1.49M
HOME
1292
DELISTED
At Home Group Inc.
HOME
-23,200
Closed -$345K
HOME
1293
PUT
DELISTED
At Home Group Inc.
HOME
-35,000
Closed -$520K
NAV
1294
CALL
DELISTED
Navistar International
NAV
-111,900
Closed -$4.87M
NAV
1295
PUT
DELISTED
Navistar International
NAV
-100,000
Closed -$4.35M
CMD
1296
CALL
DELISTED
Cantel Medical Corporation
CMD
-20,000
Closed -$879K
NGA.U
1297
DELISTED
Northern Genesis Acquisition Corp. Units, each consisting of one share of common stock and one-half
NGA.U
-15,000
Closed -$150K
GWPH
1298
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-11,000
Closed -$1.23M
VAR
1299
CALL
DELISTED
Varian Medical Systems, Inc.
VAR
-53,100
Closed -$9.13M
VAR
1300
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
-15,000
Closed -$2.58M

Similar funds

SG3 Management's Q4 2020 Portfolio in Review

As of Q4 2020, SG3 Management held 1,322 positions worth $5.25B, up 94% from $2.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

SG3 Management deployed $1.83B of net new capital in Q4 2020, opening 459 new positions and adding to 205 existing holdings. Its largest new stake was Amazon: 1,806,000 shares worth $294M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 7.9% of assets, up from 0.97% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $19.5M trimmed.

  • SG3 Management's largest Q4 2020 buy was Amazon: 1,806,000 shares worth $294M.
  • SG3 Management added most to Lennar Class A in Q4 2020, an estimated $66.8M increase.
  • SG3 Management's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $19.5M.
  • SG3 Management fully exited Beyond Meat in Q4 2020, selling an estimated $7.54M.
  • SG3 Management's ten largest holdings make up 32% of its $5.25B portfolio in Q4 2020.
  • SG3 Management opened 459 new positions and closed 337 in Q4 2020.
  • SG3 Management's portfolio value rose 94% quarter-over-quarter to $5.25B.

Based on SG3 Management's 13F filing for Q4 2020, filed 16 Feb 2021.